Obesity and Asthma: Nutrigenetic Response to Omega-3 Fatty Acids

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Asthma, Obesity

In brief

This project will assess the effectiveness of omega-3 fatty acid supplementation in controlling asthma symptoms among obese asthmatics, and will assess if a person's genes influence response to treatment (personalized medicine). This project may improve our ability to treat asthma and our understanding of the link between obesity and asthma.

Key facts

Study ID

NCT01027143

Run by

Nemours Children's Clinic

People needed

143

Starts

2010-07-01

Expected to finish

2016-10-22

Last updated by the study team

2023-09-08

Who can join

Age: 12 and older, up to 25. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• age 12-25
• BMI > 25 (age 18-25) or BMI%>85th (age 12-17) (BMI Liberalized)
• Physician diagnosis of persistent asthma
• Lung function responsiveness by bronchodilator reversibility or bronchoprovocation testing

You may not qualify if…

• pregnancy
• currently taking LTRA for asthma control
• other serious chronic medical condition
• bleeding diathesis

Where it is running

• Nemours Children's Clinic — Jacksonville, Florida, United States
• Nemours Children's Hospital/Dept of Pulmonology — Orlando, Florida, United States
• University of South Florida, Morsani College of Medicine — Tampa, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.